Journal of Urology最新文献

筛选
英文 中文
Multi-Institutional Analysis of Surgery for Lichen Sclerosus-Induced Penile Urethral Stricture: Establishing Single-Stage Urethroplasty as a Primary Treatment Option. 硬苔性阴茎尿道狭窄的多机构手术分析:建立单阶段尿道成形术作为主要治疗选择。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-01-21 DOI: 10.1097/JU.0000000000004434
Ross Hengel, Alex Vanni, Brad Erickson, Sean Elliott, Ben Breyer, Jill C Buckley, Josh Broghammer, Bryan Voelzke, Jeremy Myers, Keith Rourke
{"title":"Multi-Institutional Analysis of Surgery for Lichen Sclerosus-Induced Penile Urethral Stricture: Establishing Single-Stage Urethroplasty as a Primary Treatment Option.","authors":"Ross Hengel, Alex Vanni, Brad Erickson, Sean Elliott, Ben Breyer, Jill C Buckley, Josh Broghammer, Bryan Voelzke, Jeremy Myers, Keith Rourke","doi":"10.1097/JU.0000000000004434","DOIUrl":"10.1097/JU.0000000000004434","url":null,"abstract":"<p><strong>Purpose: </strong>Ideal treatment of lichen sclerosus (LS)-induced penile urethral strictures (PUS) remains elusive. The objective of this study was to compare multi-institutional outcomes of single-stage urethroplasty (SSU) with oral mucosal graft, staged urethroplasty, and perineal urethrostomy (PU) for treatment of LS-induced PUS.</p><p><strong>Materials and methods: </strong>Multi-institutional analysis was performed at 9 centers on men undergoing SSU, staged urethroplasty, or PU for LS-induced PUS. Meatal strictures (<2 cm), bulbar urethral involvement, and panurethral strictures (>10 cm) were excluded. The primary outcome was recurrence-free status on follow-up assessment. Secondary outcomes included 90-day complications (Clavien ≥2), erectile dysfunction, chordee, and urethrocutaneous fistula.</p><p><strong>Results: </strong>Two hundred thirty-one patients were included with a median stricture length of 5 cm and median follow-up of 53 months among those without stricture recurrence. One-, 5-, and 10-year stricture-free estimates were 90%, 80%, and 75%, respectively. Fifty-five percent (127/231) underwent SSU with oral mucosal graft, 19% (44) staged urethroplasty, and 26% (60) PU. On log-rank, there was no identifiable difference in stricture recurrence between techniques (<i>P</i> = .6) with 5-year stricture-free estimates of 82%, 76%, and 75%, respectively. On χ<sup>2</sup>, there was no significant difference in 90-day complications (7.1% vs 16% vs 8.3%; <i>P</i> = .2), erectile dysfunction (7.1% vs 4.5% vs 3.3%; <i>P</i> = .6), chordee (5.5% vs 6.8% vs 1.7%; <i>P</i> = .4), or urethrocutaneous fistula (2.4% vs 6.8% vs 0%; <i>P</i> = .09). On Cox regression, only obesity (BMI ≥35) was associated with stricture recurrence (HR, 2.31, 95% CI, 1.28-4.17; <i>P</i> = .006).</p><p><strong>Conclusions: </strong>Favorable comparative outcomes confirm SSU as a highly feasible treatment for LS-induced PUS in properly selected patients, especially when considering fewer surgeries required and preservation of an orthotopic meatus.</p>","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"628-637"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment. 编辑评论。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-01-31 DOI: 10.1097/JU.0000000000004441
Pranav Sharma
{"title":"Editorial Comment.","authors":"Pranav Sharma","doi":"10.1097/JU.0000000000004441","DOIUrl":"10.1097/JU.0000000000004441","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"578"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143066540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply by Authors. 作者回复。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-02-12 DOI: 10.1097/JU.0000000000004462
I Rivero Belenchón, C B Congregado Ruíz, G Gómez Ciriza, V Gómez Dos Santos, F J Burgos Revilla, R A Medina López
{"title":"Reply by Authors.","authors":"I Rivero Belenchón, C B Congregado Ruíz, G Gómez Ciriza, V Gómez Dos Santos, F J Burgos Revilla, R A Medina López","doi":"10.1097/JU.0000000000004462","DOIUrl":"10.1097/JU.0000000000004462","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"579-580"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143399441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Validation of MyProstateScore 2.0 Testing Using First-Catch, Non-Digital Rectal Examination Urine. myprostatcore 2.0首次检测非dre尿液的临床验证
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-01-21 DOI: 10.1097/JU.0000000000004421
Jeffrey J Tosoian, Yuping Zhang, Jacob I Meyers, Spencer Heaton, Javed Siddiqui, Lanbo Xiao, Keavash D Assani, Daniel A Barocas, Ashley E Ross, Zoey Chopra, Grace C Herron, Jacob A Edelson, Nathan J Graham, Udit Singhal, Simpa S Salami, Todd M Morgan, Ganesh S Palapattu, John T Wei, Arul M Chinnaiyan
{"title":"Clinical Validation of MyProstateScore 2.0 Testing Using First-Catch, Non-Digital Rectal Examination Urine.","authors":"Jeffrey J Tosoian, Yuping Zhang, Jacob I Meyers, Spencer Heaton, Javed Siddiqui, Lanbo Xiao, Keavash D Assani, Daniel A Barocas, Ashley E Ross, Zoey Chopra, Grace C Herron, Jacob A Edelson, Nathan J Graham, Udit Singhal, Simpa S Salami, Todd M Morgan, Ganesh S Palapattu, John T Wei, Arul M Chinnaiyan","doi":"10.1097/JU.0000000000004421","DOIUrl":"10.1097/JU.0000000000004421","url":null,"abstract":"<p><strong>Purpose: </strong>The 18-gene MyProstateScore 2.0 (MPS2) test was previously validated for detection of grade group (GG) ≥ 2 prostate cancer using post-digital rectal examination (DRE) urine. To improve ease of testing, we validated MPS2 using first-catch, non-DRE urine.</p><p><strong>Materials and methods: </strong>Patients provided first-catch urine before biopsy. MPS2 values were calculated using previously validated models differing only by extent of clinical data included biomarkers alone (BA; no clinical data), biomarkers and clinical factors (BA + CF), and biomarkers, clinical factors, and prostate volume (BA + CF + PV). The primary outcome was GG ≥ 2 cancer on biopsy. MPS2 performance and clinical consequences of testing were compared with PSA and the Prostate Cancer Prevention Trial risk calculator (PCPTrc).</p><p><strong>Results: </strong>The cohort included 266 men with median PSA 6.6 ng/mL (IQR, 4.9-9.1) of whom 103 (39%) had GG ≥ 2 cancer on biopsy. The AUC for GG ≥ 2 cancer was 57% for PSA, 62% for PCPTrc, and 71%, 74%, and 77% for MPS2 models. Under a testing approach detecting > 90% of GG ≥ 2 cancers, MPS2 testing would have avoided 36% to 42% of unnecessary biopsies, as compared with 13% using the PCPTrc. In patients with a prior negative biopsy, MPS2 testing would have avoided 44% to 53% of repeat biopsies, as compared with only 2.6% using PCPTrc.</p><p><strong>Conclusions: </strong>Using first-catch urine, MPS2 meaningfully improved the proportion of biopsies avoided relative to PCPTrc while maintaining highly sensitive detection of GG ≥ 2 cancer. Non-DRE testing provides a convenient, objective, and highly accurate testing option to reduce the need for imaging and biopsy in men with elevated PSA.</p>","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"581-589"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11981841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stimulated Raman Histology and Artificial Intelligence Provide Near Real-Time Interpretation of Radical Prostatectomy Surgical Margins. 刺激拉曼组织学和人工智能提供根治性前列腺切除术手术边缘的近实时解释。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2024-12-17 DOI: 10.1097/JU.0000000000004393
Miles P Mannas, Fang-Ming Deng, Adrian Ion-Margineanu, Christian Freudiger, Lea Lough, William Huang, James Wysock, Richard Huang, Steve Pastore, Derek Jones, Deepthi Hoskoppal, Jonathan Melamed, Daniel A Orringer, Samir S Taneja
{"title":"Stimulated Raman Histology and Artificial Intelligence Provide Near Real-Time Interpretation of Radical Prostatectomy Surgical Margins.","authors":"Miles P Mannas, Fang-Ming Deng, Adrian Ion-Margineanu, Christian Freudiger, Lea Lough, William Huang, James Wysock, Richard Huang, Steve Pastore, Derek Jones, Deepthi Hoskoppal, Jonathan Melamed, Daniel A Orringer, Samir S Taneja","doi":"10.1097/JU.0000000000004393","DOIUrl":"10.1097/JU.0000000000004393","url":null,"abstract":"<p><strong>Purpose: </strong>Balancing surgical margins and functional outcomes is crucial during radical prostatectomy for prostate cancer. Stimulated Raman histology (SRH) is a novel, real-time imaging technique that provides histologic images of fresh, unprocessed, and unstained tissue within minutes, which can be interpreted by either humans or artificial intelligence.</p><p><strong>Materials and methods: </strong>Twenty-two participants underwent robotic-assisted laparoscopic radical prostatectomy (RALP) with intraoperative SRH surgical bed assessment. Surgeons resected and imaged surgical bed tissue using SRH and adjusted treatment accordingly. An SRH convolutional neural network was developed and tested on 10 consecutive participants. The accuracy, sensitivity, and specificity of the surgical team's interpretation were compared with final histopathologic assessment.</p><p><strong>Results: </strong>A total of 121 SRH periprostatic surgical bed tissue (PSBT) assessments were conducted, an average of 5.5 per participant. The accuracy of the surgical team's SRH interpretation of resected PSBT samples was 98%, with 83% sensitivity and 99% specificity. Intraoperative SRH assessment identified 43% of participants with a pathologic positive surgical margin intraoperatively. PSBT assessment using the convolutional neural network demonstrated no overlap in tumor probability prediction between benign and tumor infiltrated samples, with mean 0.30% (IQR, 0.10%-0.43%) and 26% (IQR, 18%-34%, <i>P</i> < .005), respectively.</p><p><strong>Conclusions: </strong>SRH demonstrates potential as a valuable tool for real-time intraoperative assessment of surgical margins during RALP. This technique may improve nerve-sparing surgery and facilitate decision-making for further resection, reducing the risk of positive surgical margins and minimizing the risk of recurrence. Further studies with larger cohorts and longer follow-up periods are warranted to confirm the benefits of SRH in RALP.</p>","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"609-616"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11981856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142846749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply: Development of a Novel Prediction Tool for Response to First-Line Treatments of Monosymptomatic Nocturnal Enuresis: A Randomized, Controlled, International, Multicenter Study (DRYCHILD). 一项随机、对照、国际、多中心研究(DRYCHILD):开发一种新的预测单症状夜间遗尿症一线治疗反应的工具。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-02-07 DOI: 10.1097/JU.0000000000004438
Cecilie Siggaard Jørgensen, Søren Rittig
{"title":"Reply: Development of a Novel Prediction Tool for Response to First-Line Treatments of Monosymptomatic Nocturnal Enuresis: A Randomized, Controlled, International, Multicenter Study (DRYCHILD).","authors":"Cecilie Siggaard Jørgensen, Søren Rittig","doi":"10.1097/JU.0000000000004438","DOIUrl":"10.1097/JU.0000000000004438","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"651"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply: Development of Prediction Models for Severe Pain and Urinary Symptoms After Ureteroscopy With Ureteral Stent Placement: Results From the STENTS Study and Initial Validation of Pain Interference. 回复:输尿管镜下输尿管支架置入后严重疼痛和泌尿系统症状预测模型的建立:来自支架研究的结果和疼痛干扰的初步验证。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-02-12 DOI: 10.1097/JU.0000000000004465
Gregory E Tasian, H Henry Lai, Naim M Maalouf, Charles D Scales, Hussein R Al-Khalidi
{"title":"Reply: Development of Prediction Models for Severe Pain and Urinary Symptoms After Ureteroscopy With Ureteral Stent Placement: Results From the STENTS Study and Initial Validation of Pain Interference.","authors":"Gregory E Tasian, H Henry Lai, Naim M Maalouf, Charles D Scales, Hussein R Al-Khalidi","doi":"10.1097/JU.0000000000004465","DOIUrl":"10.1097/JU.0000000000004465","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"654-655"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143399442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endourology and Nephrolithiasis. 泌尿系统和肾结石。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-02-25 DOI: 10.1097/JU.0000000000004396
Dean G Assimos
{"title":"Endourology and Nephrolithiasis.","authors":"Dean G Assimos","doi":"10.1097/JU.0000000000004396","DOIUrl":"10.1097/JU.0000000000004396","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"663-665"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143492602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of a Clinical Decision Support Tool to Promote Guideline-Concordant Evaluations in Patients With High-Risk Microscopic Hematuria: A Cluster Randomized Quality Improvement Project. 一种临床决策支持工具促进高危显微血尿患者指南一致性评价的有效性:一项随机质量改进项目。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-01-24 DOI: 10.1097/JU.0000000000004436
Richard S Matulewicz, Sarah Tsuruo, William C King, Arielle R Nagler, Zachary S Feuer, Adam Szerencsy, Danil V Makarov, Christina Wong, Isaac Dapkins, Leora I Horwitz, Saul Blecker
{"title":"Efficacy of a Clinical Decision Support Tool to Promote Guideline-Concordant Evaluations in Patients With High-Risk Microscopic Hematuria: A Cluster Randomized Quality Improvement Project.","authors":"Richard S Matulewicz, Sarah Tsuruo, William C King, Arielle R Nagler, Zachary S Feuer, Adam Szerencsy, Danil V Makarov, Christina Wong, Isaac Dapkins, Leora I Horwitz, Saul Blecker","doi":"10.1097/JU.0000000000004436","DOIUrl":"10.1097/JU.0000000000004436","url":null,"abstract":"<p><strong>Purpose: </strong>We aimed to determine whether implementation of a clinical decision support (CDS) tool integrated into the electronic health record of a multisite academic medical center increased the proportion of patients with AUA \"high-risk\" microscopic hematuria (MH) who receive guideline-concordant evaluations.</p><p><strong>Materials and methods: </strong>We conducted a 2-arm cluster randomized quality improvement project in which 202 ambulatory sites from a large health system were randomized to either have their physicians receive at time of test results an automated CDS alert for patients with high-risk MH with associated recommendations for imaging and cystoscopy (intervention) or usual care (control). Primary outcome was met if a patient underwent both imaging and cystoscopy within 180 days from MH result. Secondary outcomes assessed individual completion of imaging, cystoscopy, or placement of imaging orders.</p><p><strong>Results: </strong>There were 917 patients randomized to intervention (n = 476) or control (n = 441) arms between October and December 2021. The percentage of eligible patients for whom the alert correctly triggered in the intervention arm was 83%. Primary outcome was achieved in 0.6% vs 0.9% (relative risk 0.69; 95% CI 0.15, 3.10) of patients in the intervention and control arms, respectively. Patients in the intervention and control groups had similar rates of completed imaging (17.7% vs 14.7%) and cystoscopy (1.5% vs 0.9%). Those in the intervention arm had a higher likelihood of CT urogram order (5.5% vs 1.1%, <i>P</i> = .003) and a nonsignificant increase in urology evaluation (11.1% vs 7.5%, <i>P</i> = .09).</p><p><strong>Conclusions: </strong>Implementing an electronic health record-integrated CDS tool to promote evaluation of patients with high-risk MH did not lead to improvements in patient completion of a full guideline-concordant evaluation. The development of an algorithm to trigger a CDS alert was demonstrated to be feasible and effective. Further multilevel assessment of barriers to evaluation is necessary to continue to improve the approach to evaluating high-risk patients with MH.</p>","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"558-567"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143033396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment. 编辑评论。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-02-12 DOI: 10.1097/JU.0000000000004463
Hriday P Bhambhvani, Mark W Farha, Behnam Nabavizadeh, Bashir Al Hussein Al Awamlh
{"title":"Editorial Comment.","authors":"Hriday P Bhambhvani, Mark W Farha, Behnam Nabavizadeh, Bashir Al Hussein Al Awamlh","doi":"10.1097/JU.0000000000004463","DOIUrl":"10.1097/JU.0000000000004463","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"607-608"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143399438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信